Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -184,678 | -143,045 | -98,882 | -52,179 | -181,119 |
| Depreciation Amortization | 1,758 | 1,341 | 899 | 3,518 | 1,672 |
| Accounts receivable | -8,643 | -8,317 | -7,607 | -1,893 | -5,199 |
| Accounts payable and accrued liabilities | 14,773 | 9,915 | 5,828 | 5,167 | 1,543 |
| Other Working Capital | 4,807 | -4,102 | -2,524 | 2,754 | -17,410 |
| Other Operating Activity | 35,826 | 37,434 | 24,763 | 6,200 | 27,085 |
| Operating Cash Flow | $-136,157 | $-106,774 | $-77,523 | $-36,433 | $-173,428 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 49 | -22,590 | 72,097 | 23,031 | 32,310 |
| PPE Investments | -5,714 | -5,715 | -5,442 | -4,567 | -281 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -4,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -4,000 |
| Investing Cash Flow | $-5,665 | $-28,305 | $66,655 | $18,464 | $28,029 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,370 | 24,370 | N/A | N/A | 72,338 |
| Debt Repayment | -7,398 | -4,824 | -2,657 | -1,351 | N/A |
| Common Stock Issued | 57,396 | 52,399 | 1,559 | 1,218 | 141,490 |
| Financing Cash Flow | $74,368 | $71,945 | $-1,098 | $-133 | $213,828 |
| Exchange Rate Effect | -142 | 50 | -27 | 86 | N/A |
| Beginning Cash Position | 128,005 | 128,005 | 128,005 | 128,005 | 59,576 |
| End Cash Position | 60,409 | 64,921 | 116,012 | 109,989 | 128,005 |
| Net Cash Flow | $-67,596 | $-63,084 | $-11,993 | $-18,016 | $68,429 |
| Free Cash Flow | |||||
| Operating Cash Flow | -136,157 | -106,774 | -77,523 | -36,433 | -173,428 |
| Capital Expenditure | -5,714 | -5,715 | -5,442 | -4,567 | -281 |
| Free Cash Flow | -141,871 | -112,489 | -82,965 | -41,000 | -173,709 |